Marta Panzeri

Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study

Heike Jacobi, Sophie Tézenas du Montcel, Peter Bauer et al. · The Lancet Neurology · 2015 · 286 citations

Longitudinal Cohort Study, Neurological Disorder, Long-term Disease Progression +4

Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data

Kathrin Reetz, Imis Dogan, Ana Sofia Costa et al. · The Lancet Neurology · 2015 · 204 citations

Neurobiology Of Disease, Neuroepidemiology, Ataxia Consortium +8

Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study

Kathrin Reetz, Imis Dogan, R.-D Hilgers et al. · The Lancet Neurology · 2016 · 150 citations

Neurodegenerative Diseases, Neurobiology Of Disease, Progression Characteristics +11

Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study

Alhassane Diallo, Heike Jacobi, Arron Cook et al. · The Lancet Neurology · 2018 · 120 citations · Full text

Longitudinal Cohort Study, Neurology, Neuroscience +2

Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2

Roberto Fancellu, Dominga Paridi, Chiara Tomasello et al. · Journal of Neurology · 2013 · 96 citations

Neuropsychological Functioning, Neuropsychology, Neurological Functioning +11